ijms-logo

Journal Browser

Journal Browser

New Insight into Extracellular Vesicles in Proliferative Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: 25 June 2024 | Viewed by 557

Special Issue Editor


E-Mail
Guest Editor
1. Biomedical Research Center, Health Sciences Technology Park, University of Granada, Granada, Spain
2. Universidad Complutense de Madrid, 28040 Madrid, Spain
Interests: extracellular vesicles; intercellular communication; pulmonary hypertension; ARDS; metastasis; mitochondrial function

Special Issue Information

Dear Colleagues,

The excessive proliferation of cells and turnover of the cellular matrix contribute significantly to the pathogenesis of several diseases, including cancer, atherosclerosis, rheumatoid arthritis, psoriasis, idiopathic pulmonary fibrosis, pulmonary hypertension, scleroderma and cirrhosis of the liver. The mechanisms that control the spread of damage in these types of pathologies are not entirely clear. In recent years, interest in the different types of extracellular vesicles (exosomes, microvesicles, apoptotic bodies or newly identified subpopulations such as oncosomes, migrasomes, exophers, etc.) and their roles as mediators of intercellular and interorgan communication has increased exponentially. Extracellular vesicles (EVs) are nanosized lipid membrane-enclosed vesicles that may contain nucleic acids (DNAs, mRNAs, miRNAs, lncRNAs, piRNAs, etc.), lipids, proteins and organelles and may participate in the dissemination of the proliferative phenotype or in the possible therapeutic effects of these types of pathologies.

In this Special Issue, we aim to highlight the role of extracellular vesicles in proliferative diseases. Therefore, we invite researchers to contribute original research and up-to-date review articles that increase knowledge about the mechanisms involved in the synthesis, cargo or internalization of these vesicles. We also welcome articles that explore their use as biomarkers.

Dr. Sergio Esquivel-Ruiz
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • proliferation
  • extracellular vesicles
  • intercellular communication
  • vesicle cargo
  • therapeutic applications
  • biomarkers

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 3773 KiB  
Article
Triple-Negative Breast Cancer EVs Modulate Growth and Migration of Normal Epithelial Lung Cells
by Ilaria Leone, Jessie Santoro, Andrea Soricelli, Antonio Febbraro, Antonio Santoriello and Barbara Carrese
Int. J. Mol. Sci. 2024, 25(11), 5864; https://doi.org/10.3390/ijms25115864 - 28 May 2024
Viewed by 281
Abstract
Breast cancer is the most common cancer amongst women worldwide. Recently, owing to screening programs and new technologies, the survival rate has increased significantly. Breast cancer can potentially develop metastases, and, despite them, lung metastases generally occur within five years of breast cancer [...] Read more.
Breast cancer is the most common cancer amongst women worldwide. Recently, owing to screening programs and new technologies, the survival rate has increased significantly. Breast cancer can potentially develop metastases, and, despite them, lung metastases generally occur within five years of breast cancer diagnosis. In this study, the objective was to analyze the effect of breast cancer-derived EVs on a lung epithelial cell line. BEAS-2B cells were treated with extracellular vesicles (EVs) derived from triple-negative breast cancer cells (TNBCs), e.g., MDA-MB-231 and HS578T, separated using differential ultracentrifugation. We observed an increased growth, migration, and invasiveness of normal epithelial lung cells over time in the presence of TNBC EVs compared to the control. Therefore, these data suggest that EVs released by tumor cells contain biological molecules capable of influencing the pro-tumorigenic activity of normal cells. Exploring the role of EVs in oncology research and their potential cargo may be novel biomarkers for early cancer detection and further diagnosis. Full article
(This article belongs to the Special Issue New Insight into Extracellular Vesicles in Proliferative Diseases)
Show Figures

Figure 1

Back to TopTop